PHAT

$12.67+0.07 (+0.60%)

Pre-Market$12.75+0.08 (+0.63%)· Last close May 6

Phathom Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases in the United States.

Overview Intraday ResearchPRO BacktestPRO Ask AIPRO TranscriptsPRO StatementsPRO